Drug intelligence / Profile preview

agarose gel

Development stage: Unknown
Lead developer: Advanced Aesthetic Technologies
Modality: Nanoparticles → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems, Device-based Delivery → Drug Delivery Systems
Administration: Intradermal

Overview

Agarose gel is an injectable biomaterial primarily developed as a dermal filler for cosmetic applications. It is being evaluated for its efficacy and safety in correcting moderate to severe wrinkles, specifically targeting areas such as the neck and nasolabial folds. The product functions by physically augmenting the dermal tissue to reduce the visible signs of aging and improve skin contour.

Brand names: AlgenessAlgeness VLAlgeness LDAlgeness DFAlgeness HD
Other names: injectable agarose gelagarose gel for injection

Beyond the preview

Go deeper on agarose gel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on agarose gel.

Explore the full profile